Rigel Pharmaceuticals (RIGL)

Rigel Pharmaceuticals (RIGL) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	27.22% 35.79	28.13	26.89	26.07	51.28
Cost Of Revenue	198.90% 3.79	1.268	1.075	0.977	0.342
Gross Profit	19.12% 32.00	26.87	25.81	25.09	50.94
Operating Expenses	4.13% 30.04	31.33	31.08	37.82	48.86
Interest Income/Expense	0.42% 1.907	1.899	1.862	1.204	1.107
Benefits Costs and Expenses	7.53% 35.05	32.60	32.15	39.61	49.88
Costs And Expenses	3.76% 33.83	32.60	32.15	38.80	49.20
Operating Income/Loss	144.03% 1.966	-4.465	-5.267	-12.72	2.079
Income/Loss From Continuing Operations Before Tax	116.51% 0.737	-4.465	-6.60	-13.54	1.401
Income/Loss From Continuing Operations After Tax	112.95% 0.737	-5.692	-6.60	-13.54	1.401
Net Income/Loss	112.95% 0.737	-5.692	-6.60	-13.54	1.401
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.93% 0.12	174.36	173.75	173.57	0.15
Diluted Average Shares	99.93% 0.12	174.36	173.75	173.57	0.15
Basic Earnings Per Share	133.33% 0.010	-0.03	-0.04	-0.08	0.010
Diluted Earnings Per Share	133.33% 0.010	-0.03	-0.04	-0.08	0.010
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-